With our growing and aging population, more people are becoming concerned about Alzheimer's disease. When is it appropriate to be tested, and how do people understand the results and risks?

The old saying, “If you want something done right, you have to do it yourself," appears to apply to osteoporosis diagnosis and care.

Making a drug that works to fight several parts of a disease can be hard, especially for a mysterious illness like multiple sclerosis (MS). This is a problem that drugmaker Sanofi is currently dealing with.

Bone loss is common in people who have had multiple sclerosis (MS) for a long time. Now, it seems like people who just found out they have MS may also have weaker bones.

Parkinson's disease patients often have difficulty with quick movements, which can add difficulty to their daily lives. Adding sound or visual cues can improve movement and speed. The answer might be as simple as virtual reality games.

Scientists have long linked chronic stress to brain degeneration. Now they may have identified the connection. These findings could ultimately aid in understanding and treating Alzheimer's disease.

A variety of neurodegenerative diseases including Parkinson's disease are defined by trademark protein clusters. Scientists have discovered a small protein that could aid in preventing Parkinson's disease.

A protein created by a gene that causes Alzheimer’s disease prevents the brain from ridding itself of amyloid beta, the main culprit in the plaques and tangles that are hallmarks of the disease.

Multiple sclerosis (MS) is a somewhat mysterious disease. So, when researchers found that breastfeeding may lower a woman's risk of a crippling episode of the disease, mother's with MS became hopeful.

An international group of physical therapists (PTs) agree that confidence, motivation and energy are concepts that will be added to the "Body Functions" category.